These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11196176)

  • 1. High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.
    Rigaud G; Missiaglia E; Moore PS; Zamboni G; Falconi M; Talamini G; Pesci A; Baron A; Lissandrini D; Rindi G; Grigolato P; Pederzoli P; Scarpa A
    Cancer Res; 2001 Jan; 61(1):285-92. PubMed ID: 11196176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
    Guo SS; Wu AY; Sawicki MP
    World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity analysis in uterine cervical adenocarcinoma.
    Miyai K; Furugen Y; Matsumoto T; Iwabuchi K; Hirose S; Kinoshita K; Fujii H
    Gynecol Oncol; 2004 Jul; 94(1):115-20. PubMed ID: 15262128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours.
    Pizzi S; D'Adda T; Azzoni C; Rindi G; Grigolato P; Pasquali C; Corleto VD; Delle Fave G; Bordi C
    J Pathol; 2002 Apr; 196(4):401-7. PubMed ID: 11920735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
    Grundei T; Vogelsang H; Ott K; Mueller J; Scholz M; Becker K; Fink U; Siewert JR; Höfler H; Keller G
    Clin Cancer Res; 2000 Dec; 6(12):4782-8. PubMed ID: 11156235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
    Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
    Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity in pancreatic endocrine tumors.
    Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
    Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional allelic loss in gastric carcinoma correlates with growth patterns.
    Choi SW; Park SW; Lee KY; Kim KM; Chung YJ; Rhyu MG
    Oncogene; 1998 Nov; 17(20):2655-9. PubMed ID: 9840929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
    Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
    Pourani J; Kaserer K; Pfragner R
    Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
    Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
    Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
    Ott K; Vogelsang H; Mueller J; Becker K; Müller M; Fink U; Siewert JR; Höfler H; Keller G
    Clin Cancer Res; 2003 Jun; 9(6):2307-15. PubMed ID: 12796400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors.
    Ebrahimi SA; Wang EH; Wu A; Schreck RR; Passaro E; Sawicki MP
    Cancer Res; 1999 Jan; 59(2):311-5. PubMed ID: 9927038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors.
    Guo SS; Arora C; Shimoide AT; Sawicki MP
    Mol Cell Endocrinol; 2002 Apr; 190(1-2):109-14. PubMed ID: 11997184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome.
    Schurr P; Wolter S; Kaifi J; Reichelt U; Kleinhans H; Wachowiak R; Yekebas E; Strate T; Kalinin V; Simon R; Sauter G; Schaefer H; Izbicki J
    Clin Cancer Res; 2006 Sep; 12(17):5151-7. PubMed ID: 16951233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.